Company · CIK 1161924
MiddleBrook Pharmaceuticals, Inc.
| CIK | 1161924 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MD |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2003-11-25 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-154431 | 2008-10-17 | 2008-11-24 | 2 | |
| 333-149006 | 2008-02-01 | 2008-02-11 | 2 | |
| 333-147637 | 2007-11-27 | 2007-12-12 | 2 | |
| 333-142819 | 2007-05-10 | 2007-05-23 | 2 | |
| 333-139614 | 2006-12-22 | 2006-12-29 | 2 | |
| 333-124926 | 2005-05-13 | 2005-05-13 | 1 | |
| 333-107599 | 2003-08-01 | 2003-10-17 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2008-11-24 | EFFECTDeclared effective | 333-154431 | 9999999995-08-003500 |
| 2008-10-17 | S-3Shelf registered | 333-154431 | 0000950133-08-003394 |
| 2008-02-11 | EFFECTDeclared effective | 333-149006 | 9999999995-08-000515 |
| 2008-02-01 | S-3Shelf registered | 333-149006 | 0000950133-08-000346 |
| 2007-12-12 | EFFECTDeclared effective | 333-147637 | 9999999995-07-004885 |
| 2007-11-27 | S-3Shelf registered | 333-147637 | 0000950133-07-004730 |
| 2007-05-23 | EFFECTDeclared effective | 333-142819 | 9999999995-07-002075 |
| 2007-05-10 | S-3Shelf registered | 333-142819 | 0000950133-07-002253 |
| 2006-12-29 | EFFECTDeclared effective | 333-139614 | 9999999995-07-000019 |
| 2006-12-22 | S-3Shelf registered | 333-139614 | 0000950133-06-005409 |
| 2005-05-13 | S-3Shelf registered | 333-124926 | 0000950133-05-002246 |
| 2003-10-17 | 424B4Final prospectus | 333-107599 | 0000950123-03-011437 |
| 2003-10-09 | S-1/AAmendment | 333-107599 | 0000950123-03-011208 |
| 2003-09-29 | S-1/AAmendment | 333-107599 | 0000950123-03-010920 |
| 2003-09-05 | S-1/AAmendment | 333-107599 | 0000950123-03-010144 |
| 2003-08-01 | S-1Registration filed | 333-107599 | 0000950123-03-008868 |